Mutations in the human telomerase RNA component (hTR), the telomerase ribonucleoprotein component dyskerin (DKC1) and the poly(A) RNase (PARN) can lead to reduced levels of hTR and to dyskeratosis congenita (DC). However, the enzymes and mechanisms responsible for hTR degradation are unknown. We demonstrate that defects in dyskerin binding lead to hTR degradation by PAPD5-mediated oligoadenylation, which promotes 3′-to-5′ degradation by EXOSC10, as well as decapping and 5′-to-3′ decay by the cytoplasmic DCP2 and XRN1 enzymes. PARN increased hTR levels by deadenylating hTR, thereby limiting its degradation by EXOSC10. Telomerase activity and proper hTR localization in dyskerin-or PARN-deficient cells were rescued by knockdown of DCP2 and/or EXOSC10. Prevention of hTR RNA decay also led to a rescue of localization of DC-associated hTR mutants. These results suggest that inhibition of RNA decay pathways might be a useful therapy for some telomere pathologies. npg
a r t i c l e s Telomere elongation by telomerase is required for continuous proliferation of human stem cells 1 . Insufficient telomerase levels are responsible for the inherited disorder DC and contribute to more common diseases such as aplastic anemia and idiopathic pulmonary fibrosis 2 . Telomerase is a ribonucleoprotein (RNP) enzyme, and disease-causing mutations have been identified in its RNA component (hTR) and its catalytic protein subunit (hTERT), and in the small nucleolar ribonucleoprotein dyskerin, which stabilizes hTR in the nucleus even in the absence of hTERT [3] [4] [5] [6] . More recently, mutations in PARN have been identified in patients with a severe form of DC as well as those with idiopathic pulmonary fibrosis [7] [8] [9] . An unaddressed issue is how hTR is degraded and the interplay between the relevant RNA degradation systems and mutations in PARN and dyskerin. Our goal was to investigate the quality-control pathways of hTR when dyskerin or PARN is depleted from cells, and the ability of inhibition of RNA quality-control pathways to rescue hTR levels and function under these conditions.
RESULTS

Loss of dyskerin binding leads to hTR degradation
To determine how hTR is degraded when dyskerin levels are reduced, we examined how knockdown of RNA-decay enzymes affected endogenous hTR levels when dyskerin was depleted in HeLa cells. We observed that knockdown of dyskerin reduced hTR to 17% of wild-type levels (Fig. 1a) , but this effect was partially rescued by knockdown of DCP2 (~2.5-fold, from 17% to 41% of control) or of XRN1 (~1.6-fold, from ~17% to 28% of control) ( Fig. 1b) . DCP2 and XRN1 are components of a pathway involving cytoplasmic decapping and 5′-to-3′ decay. We also observed that hTR levels after DKC1 knockdown were rescued by knockdown of the nuclear 3′-to-5′ exonuclease EXOSC10 (~2.6-fold, from 17% to 45% of control) (Fig. 1b,c) . Moreover, double knockdown of EXOSC10 and either DCP2 or XRN1 restored hTR levels in the dyskerin-depleted cells, to ~70% of the wild-type levels.
To determine whether these differences in RNA levels were due to changes in hTR stability, we measured the decay of hTR after inhibition of transcription with actinomycin D. As expected, we observed that in dyskerin-knockdown cells, hTR was degraded faster than in control cells ( Fig. 1d) . More importantly, knockdown of DCP2, EXOSC10 or both led to a decrease in hTR decay in the dyskerinknockdown cells ( Fig. 1d,e ). These results indicate that in the absence of dyskerin, hTR can be degraded by DCP2-mediated decapping, thus leading to 5′-to-3′ degradation by XRN1 as well as by nuclear 3′-to-5′ degradation by EXOSC10.
The exonucleolytic activity of EXOSC10 is enhanced by the poly(A) polymerase PAPD5, which adds 3′-oligo(A) tails, thus promoting substrate recognition by EXOSC10 (refs. [10] [11] [12] [13] [14] . To determine whether PAPD5 affected hTR degradation, we examined whether PAPD5 knockdown could rescue the reduced hTR levels in dyskerin-deficient cells. We observed that PAPD5 knockdown increased hTR levels 2.4-fold (from 17% to 40% of control) in the dyskerin knockdown ( Fig. 1f) . Consistently with PAPD5 adding oligo(A) tails to hTR, a subset of endogenous hTR population exists in an oligoadenylated state 15 .
Pathogenic point mutations in hTR that disrupt either the dyskerin-binding site (A377G, 378-415∆) or the biogenesispromoting (BIO) box (C408G) also reduce hTR levels 6, 16, 17 . To determine whether these reduced levels could also be rescued by inhibition of RNA decay enzymes, we transfected wild-type or mutant hTR along with hTERT into U2OS cells, which do not express endogenous hTR detectable by northern blotting, and examined hTR levels by northern blotting with or without knockdown of nucleases ( Supplementary Fig. 1a ). Compared to the wild-type hTR, the A377G, C408G and 378-415∆ mutants had <20% steady-state hTR levels in U2OS cells (Fig. 1g) . The reduced levels of the A377G and C408G hTR RNAs were partially rescued by knockdown of DCP2 (three-fold), XRN1 (four-fold), EXOSC10 (four-fold) or PAPD5 (two-fold) ( Fig. 1h and Supplementary Fig. 1b-d) . Knockdown of several other RNA-decay enzymes did not rescue hTR levels ( Fig. 1h and Supplementary Fig. 1e ).
To test whether the low levels of mutant hTR might be due to reduced transcription rather than to RNA stability, we examined the association of RNA polymerase (Pol) II with the hTR-encoding gene by chromatin immunoprecipitation (ChIP) in U2OS cells transfected with plasmids encoding either wild-type or C408G RNA. We observed that both genes showed a similar level of RNA Pol II occupancy, and the C408G plasmid-borne copy showed slightly higher occupancy ( Supplementary Fig. 1f ). These results suggest that these mutations in hTR do not reduce hTR transcription, but instead RNA qualitycontrol pathways lead to low levels of mutant hTR under these conditions. Thus, when either dyskerin is deficient or its binding site in hTR is mutated, hTR molecules are degraded by PAPD5-mediated adenylation coupled to EXOSC10-mediated 3′-to-5′ degradation as well as degradation by DCP2 and XRN1.
EXOSC10 competes with PARN for processing of mature hTR
The degradation of hTR by PAPD5-promoted EXOSC10 nucleolytic activity led us to hypothesize that PARN might contribute to hTR (e) Relative abundance of oligoadenylated reads at the mature hTR 3′ end from cells with different components knocked down. Reads were normalized to the total number of mature end-containing reads under each condition. ***P <0.001 by two tailed Student's t test for total number of reads in each condition shown in Supplementary Table 1 .
a r t i c l e s npg a r t i c l e s stability by removing oligo(A) tails added by PAPD5, thereby limiting the ability of EXOSC10 to degrade hTR ( Fig. 2a) . Consistently with this model, PARN knockdown in HeLa cells led to reduced levels of hTR, and those levels were partially restored by knockdown of PAPD5 or EXOSC10 (Fig. 2b) . Moreover, measurement of hTR stability after inhibition of transcription with actinomycin D showed that PARN knockdown led to a reduction in the stability of hTR in HeLa cells, an effect that was partially rescued by knockdown of EXOSC10 ( Fig. 2c,d) . We interpret this observation to suggest that PARN and EXOSC10 compete for hTR 3′-end processing ( Fig. 2a) .
To examine how 3′ adenylation of hTR is modulated by these enzymes, we sequenced the 3′ end of hTR in control cells and in cells with knockdown of PARN, EXOSC10, PAPD5, or both PARN and EXOSC10. We observed a fraction of hTR with oligo(A) tails, consistently with earlier results, and this oligoadenylated fraction decreased after knockdown of PAPD5 and increased after knockdown of PARN, EXOSC10, or both PARN and EXOSC10 ( Fig. 2e and Supplementary Table 1) . The approximately five-fold reduction in the percentage of adenylated hTR molecules in the PAPD5 knockdown suggests that PAPD5 adenylates hTR. Moreover, the increase in adenylated hTR molecules after knockdown of PARN, EXOSC10, or both PARN and EXOSC10 provides evidence that PARN and EXOSC10 deadenylate and/or degrade adenylated hTR molecules ( Fig. 2a) . We also observed that the length distribution of residual oligo(A) tail lengths on the mature 3′ end of hTR slightly decreased after PAPD5 knockdown and increased after knockdown of PARN, or both PARN and EXOSC10 ( Supplementary Fig. 2 ). Oligo(A) tails at the mature 3′ end were slightly shorter in the EXOSC10 knockdown, a result consistent with increased PARN activity in the absence of EXOSC10-mediated degradation (Supplementary Fig. 2) . Thus, PARN competes with PAPD5 and limits the length of oligo(A) tails on hTR, thereby preventing EXOSC10-mediated degradation of hTR.
EXOSC10 and PARN compete for PAPD5-mediated 3′-end processing
The sequencing of the 3′ ends of hTR and their adenylation status also provided several observations suggesting that PAPD5, PARN and EXOSC10 also affect 3′-end processing and/or the degradation of 3′-extended hTR precursors. Compared to the mature hTR 3′ end, where 2.3% of the total reads were oligoadenylated, the hTR molecules that extended up to 10 nt past the mature 3′ end had a much greater proportion of oligoadenylation (74.5% of total reads; Supplementary Tables 1 and 2) . The percentage of these adenylated 3′ extended molecules decreased after PAPD5 knockdown (down to 60%; Supplementary Table 2 ) and increased after knockdown of either PARN (up to 90.1%; Supplementary Table 2 ) or PARN and EXOSC10 (87.4%; Supplementary Table 2 ).
We also observed that PARN knockdown led to an increase in the total amount of 3′-extended hTR molecules detected, from 7.2% in the control to 15.7% after PARN knockdown (Supplementary Table 2 ). We interpret this result to suggest that PARN promotes the efficient 3′-end processing of at least a subset of hTR molecules, if 3′-end maturation requires deadenylation before trimming to form the mature end.
Rescue of telomerase activity in DKC1-or PARN-depleted cells
Our results indicated that knockdown of RNA-decay enzymes restored hTR levels in dyskerin-or PARN-deficient cells. To determine whether the stabilized hTR molecules were functional, we examined the endogenous telomerase activity in dyskerin-or PARN-deficient HeLa cells, with or without rescue of hTR levels by knockdown of various nucleases. Immunoprecipitation with an anti-TERT antibody allowed direct assay of the low endogenous telomerase activity 18 .
We observed that knockdown of dyskerin in HeLa cells reduced telomerase activity (Fig. 3a) , but this activity was partially restored by knockdown of DCP2 or EXOSC10 (Fig. 3a,b) . Coknockdown of dyskerin along with DCP2 and EXOSC10 restored telomerase activity to essentially wild-type levels, in correlation with an increase in hTR levels to ~70% of wild-type levels under this condition (Figs. 3b  and 1b) . Similarly, PARN-deficient cells showed reduced telomerase activity, and this decrease was rescued by coknockdown of PARN and either EXOSC10 or PAPD5, similarly to what was observed for the hTR levels in the cells under the same conditions (comparison of Fig. 3c,d and Fig. 2b) . These results indicate that the defect in telomerase activity in dyskerin-or PARN-deficient cells is due to the reduced levels of hTR, and restoration of the RNA by inhibiting its decay is sufficient to restore telomerase activity. a r t i c l e s
Rescue of hTR subcellular localization by decay inhibition
Normally, hTR is predominantly localized to Cajal bodies and telomeres (depending on the cell-cycle stage) in telomerase-positive human cells [19] [20] [21] . Because knockdown of nucleases increased hTR levels in cells that were deficient in dyskerin or PARN, we determined whether these hTR RNPs could localize to Cajal bodies by fluorescence in situ hybridization (FISH). We observed that, similarly to previously reported results 19, 21 , endogenous hTR localized to Cajal bodies in essentially all HeLa cells (Fig. 4a) . However, in cells with knockdown of dyskerin or PARN, we observed a reduction in FISH signal that was consistent with the reduced hTR levels: only 8% or 14% of the cells maintained hTR in Cajal bodies after knockdown of DKC1 or PARN, respectively (Fig. 4a,b) . Surprisingly, in a fraction of the cells with dyskerin (23%) or PARN (13%) knocked down, we observed a residual FISH signal for hTR in cytoplasmic puncta that, to our knowledge, have not been previously described (Fig. 4a) . We refer to these puncta as cytoplasmic TER (cyTER) bodies.
We observed a similar aberrant localization of hTR when we analyzed hTR point mutations. In U2OS cells transfected with hTERT and wild-type hTR, we observed that hTR localized to telomeres along with Cajal bodies that have been termed neo-Cajal bodies 22 (Fig. 5a) . npg a r t i c l e s In contrast, cells expressing hTERT and the A377G or C408G mutant hTR showed reduced FISH signal for hTR and loss of hTR association with Cajal bodies, and only 21% and 18% of cells, respectively, still showed hTR in Cajal bodies (Supplementary Fig. 3a) . The residual hTR signal was present in cyTER bodies (82% of cells for C408G hTR) ( Supplementary Fig. 3a,b) .
DAPI
To test whether cyTER bodies might represent sites of promiscuous hybridization of the hTR probes, we performed a FISH experiment with a combination of differently labeled hTR probes. For wild-type hTR, the two different probes clearly colocalized with Cajal bodies. For the C408G mutant, the probes colocalized with cyTER bodies but not Cajal bodies (Supplementary Fig. 4a ). cyTER bodies also did not colocalize with DCP1 or SMN, thus indicating that these assemblies were not processing (P) bodies, U small nuclear RNP (U) bodies or Gemini of coiled bodies (Gems) (Supplementary Fig. 4b) . Thus, defects in PARN or dyskerin binding reduce hTR levels and disrupt proper hTR localization to Cajal bodies and telomeres, and have led us to identify of a new cytoplasmic pool of hTR.
An important result was that knockdown of DCP2 and/or EXOSC10 restored hTR levels and proper localization of defective hTR RNPs, as detected by FISH, in three cases. First, in dyskerin-knockdown cells, knockdown of EXOSC10, DCP2 or both led to restoration of hTR localization to Cajal bodies (29%, 45% and 84% of cells, respectively) ( Fig. 4a) . For EXOSC10 knockdown, the RNA sometimes localized to sites other than Cajal bodies in the nucleus, which might have been telomeres. Second, we observed that knockdown of EXOSC10 in PARN-deficient cells restored the localization of hTR to Cajal bodies (85% of cells) (Fig. 4b) . Finally, we observed that knockdown of DCP2, EXOSC10 or both restored the localization of A377G hTR to Cajal bodies (Fig. 5b) . Thus, stabilization of hTR in either dyskerin-or PARN-deficient cells restored both telomerase activity ( Fig. 3) and localization to Cajal bodies (Fig. 4) .
DISCUSSION
The absence of dyskerin protein or the presence of mutations in hTR that alter RNP assembly leads to decreased hTR levels, insufficient telomerase and failure to maintain human stem cells. Here we identified two independent quality-control pathways for hTR in response to defects in dyskerin protein or mutations in hTR: (i) decapping followed by XRN1-mediated 5′-to-3′ degradation and (ii) 3′-to-5′ degradation by the nuclear exosome. Notably, we showed that these reduced levels of hTR and of telomerase activity can be Figure 6 Model for hTR biogenesis, depicting competition among pathways of hTR assembly with H/ACA small nucleolar RNP proteins; 3′-end processing by PAPD5 and PARN and RNA degradation by EXOSC10; and cytoplasmic export and RNA degradation by DCP2 and XRN1.
a r t i c l e s rescued by knockdown of DCP2, XRN1 or EXOSC10 ( Fig. 1 and  Supplementary Fig. 1) .
Evidence that the decapping, XRN1-dependent pathway and the nuclear exosome pathway are independent came from our observation that double knockdown of EXOSC10 and either DCP2 or XRN1 had an additive effect on hTR levels (Fig. 1) . Additional evidence that the nuclear exosome affects hTR degradation came from the observation that knockdown of the nuclear exosome led to the accumulation of 3′-extended hTR molecules as well as an increase in the levels of mature hTR 23, 24 .
These observations support a model for hTR biogenesis that involves competition between dyskerin binding and hTR decay in the cell (Fig. 6) . Under normal conditions, dyskerin binding allows hTR accumulation, either through cotranscriptional association or through cytoplasmic binding followed by nuclear reimport. When dyskerin binding to hTR is compromised, hTR can be degraded in the nucleus by EXOSC10 or can be exported to the cytoplasm and degraded by DCP2-XRN1.
Several observations provided a molecular explanation for the requirement of PARN for hTR stability, wherein it specifically removes hTR oligo(A) tails added by PAPD5, which would otherwise recruit EXOSC10 (the nuclear exosome) for hTR degradation. First, knockdown of PARN led to reduced levels of hTR (Fig. 2) , owing to faster hTR degradation 25 , which was rescued by knockdown of EXOSC10 or PAPD5 (Fig. 2) . Second, we observed that the oligo(A) tails on hTR were reduced when PAPD5 was depleted and increased after depletion of PARN or EXOSC10 (Fig. 2) . Because PARN is specific for adenosine residues, deadenylation by PARN would limit the recruitment of EXOSC10 to hTR, thereby increasing its stability.
Our observations suggest that PARN is not primarily required for hTR biogenesis, because when PARN was limiting, knockdown of EXOSC10 or PAPD5 restored hTR levels (Fig. 2) , telomerase activity ( Fig. 3) and localization of hTR to Cajal bodies ( Fig. 4) . Instead, we suggest that PARN continually functions to remove oligo(A) tails added to hTR by PAPD5. This is likely to be a general phenomenon wherein stable noncoding nuclear RNAs with accessible 3′ ends are constant substrates for PAPD5, and therefore their equilibrium concentrations would be maintained by PARN's removal of such oligo(A) tails, thus limiting their degradation by the nuclear exosome.
There are two important implications of our observations that defects in hTR levels, telomerase activity and proper subcellular location of hTR in cells deficient in PARN or dyskerin were rescued by knockdown of EXOSC10, PAPD5 and/or DCP2. First, neither PARN nor dyskerin is required for the biogenesis, activity or, in certain cases, localization of hTR. Second, this restoration of function suggests that inhibition of hTR degradation may be a viable therapeutic strategy for telomere pathologies. As such, DC is now seen to fall in the broader category of 'RNP hypoassembly diseases' , in which a competing RNA quality-control pathway degrades the RNA and limits RNP assembly, owing to reduced binding by the RNA's protein partners 26 .
A surprising observation was that in cells deficient in PARN or dyskerin, or those expressing mutant hTR molecules, hTR accumulated in discrete cytoplasmic foci, referred to as cyTER bodies, in a fraction of cells. This result provides evidence that hTR can be exported from the nucleus, as described previously for the budding yeast telomerase RNA 27, 28 , and it reveals a completely new aspect of human telomerase RNA cell biology. These foci do not colocalize with markers of P bodies or Gems and thus are of unknown composition. Future work should reveal whether these puncta are sites of hTR storage or whether they are involved in normal hTR biogenesis, possibly by licensing the hTR RNP for nuclear import.
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